IBD patients are on chronic medication, such as 5-aminosalicylates, corticosteroids, and biopharmaceuticals including anti-tumor necrosis factor (TNF) and anti-interleukin (IL)-12/23p40 antibodies2. Here, TNF is linked to inflammatory bowel disease.